These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8988963)

  • 1. Behavioral and neuroendocrine responses to m-chlorophenylpiperazine in subtypes of alcoholics and in healthy comparison subjects.
    George DT; Benkelfat C; Rawlings RR; Eckardt MJ; Phillips MJ; Nutt DJ; Wynne D; Murphy DL; Linnoila M
    Am J Psychiatry; 1997 Jan; 154(1):81-7. PubMed ID: 8988963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal, psychological, and alcohol craving changes after m-chlorophenylpiperazine administration in alcoholics.
    Buydens-Branchey L; Branchey M; Fergeson P; Hudson J; McKernin C
    Alcohol Clin Exp Res; 1997 Apr; 21(2):220-6. PubMed ID: 9113256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects.
    Krystal JH; Webb E; Cooney NL; Kranzler HR; Southwick SW; Heninger GR; Charney DS
    Am J Psychiatry; 1996 Jan; 153(1):83-92. PubMed ID: 8540598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin hypothesis of winter depression: behavioral and neuroendocrine effects of the 5-HT(1A) receptor partial agonist ipsapirone in patients with seasonal affective disorder and healthy control subjects.
    Schwartz PJ; Turner EH; Garcia-Borreguero D; Sedway J; Vetticad RG; Wehr TA; Murphy DL; Rosenthal NE
    Psychiatry Res; 1999 Apr; 86(1):9-28. PubMed ID: 10359479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of criteria for subgrouping alcoholics: the primary/secondary diagnostic scheme versus variations of the type 1/type 2 criteria.
    Anthenelli RM; Smith TL; Irwin MR; Schuckit MA
    Am J Psychiatry; 1994 Oct; 151(10):1468-74. PubMed ID: 8092340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic variants of the serotonin(2C) receptor and neuroendocrinological responses to the serotonin(2C) receptor agonist m-chlorophenylpiperazine in healthy male volunteers.
    Kühn KU; Quednow BB; Bagli M; Meyer K; Feuchtl A; Westheide J; Frahnert C; Maier W; Rao ML
    Pharmacopsychiatry; 2002 Nov; 35(6):226-30. PubMed ID: 12518270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral, physiological and neuroendocrine responses in healthy volunteers to m-chlorophenylpiperazine (m-CPP) with and without ondansetron pretreatment.
    Broocks A; Briggs NC; Pigott TA; Hill JL; Canter SK; Tolliver TJ; Baldemore D; Murphy DL
    Psychopharmacology (Berl); 1997 Mar; 130(2):91-103. PubMed ID: 9106905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender-dependent dissociation between oxytocin but not ACTH, cortisol or TSH responses to m-chlorophenylpiperazine in healthy subjects.
    Bagdy G; Arato M
    Psychopharmacology (Berl); 1998 Apr; 136(4):342-8. PubMed ID: 9600579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects.
    Anand A; Charney DS; Delgado PL; McDougle CJ; Heninger GR; Price LH
    Am J Psychiatry; 1994 Nov; 151(11):1626-30. PubMed ID: 7943451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The criteria of Cloninger et al. and von Knorring et al. for subgrouping alcoholics: a comparison in a clinical population.
    Lamparski DM; Roy A; Nutt DJ; Linnoila M
    Acta Psychiatr Scand; 1991 Dec; 84(6):497-502. PubMed ID: 1792921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of serum cholesterol levels on meta-chlorophenylpiperazine-evoked neuroendocrine responses in healthy subjects.
    Terao T; Yoshimura R; Ohmori O; Takano T; Takahashi N; Iwata N; Suzuki T; Abe K
    Biol Psychiatry; 1997 May; 41(9):974-8. PubMed ID: 9110103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral and endocrine responses to clomipramine in panic disorder patients with or without alcoholism.
    George DT; Nutt DJ; Rawlings RR; Phillips MJ; Eckardt MJ; Potter WZ; Linnoila M
    Biol Psychiatry; 1995 Jan; 37(2):112-9. PubMed ID: 7718674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of ethanollike effects elicited by serotonergic and noradrenergic mechanisms.
    Krystal JH; Webb E; Cooney N; Kranzler HR; Charney DS
    Arch Gen Psychiatry; 1994 Nov; 51(11):898-911. PubMed ID: 7944878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased psychological responses and divergent neuroendocrine responses to m-CPP and ipsapirone in patients with panic disorder.
    Broocks A; Bandelow B; George A; Jestrabeck C; Opitz M; Bartmann U; Gleiter CH; Meineke I; Roed IS; Rüther E; Hajak G
    Int Clin Psychopharmacol; 2000 May; 15(3):153-61. PubMed ID: 10870873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans.
    Mueller EA; Murphy DL; Sunderland T
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1179-84. PubMed ID: 4055985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased neuroendocrine responses to meta-chlorophenylpiperazine (m-CPP) but normal responses to ipsapirone in marathon runners.
    Broocks A; Meyer T; George A; Hillmer-Vogel U; Meyer D; Bandelow B; Hajak G; Bartmann U; Gleiter CH; Rüther E
    Neuropsychopharmacology; 1999 Feb; 20(2):150-61. PubMed ID: 9885795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of m-chlorophenylpiperazine on regional brain glucose utilization: a positron emission tomographic comparison of alcoholic and control subjects.
    Hommer D; Andreasen P; Rio D; Williams W; Ruttimann U; Momenan R; Zametkin A; Rawlings R; Linnoila M
    J Neurosci; 1997 Apr; 17(8):2796-806. PubMed ID: 9092601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The meta-chlorophenylpiperazine challenge test in cocaine addicts: hormonal and psychological responses.
    Buydens-Branchey L; Branchey M; Fergeson P; Hudson J; McKernin C
    Biol Psychiatry; 1997 Jun; 41(11):1071-86. PubMed ID: 9146818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily administration of m-chlorophenylpiperazine to healthy human volunteers rapidly attenuates many of its behavioral, hormonal, cardiovascular and temperature effects.
    Benjamin J; Greenberg BD; Murphy DL
    Psychopharmacology (Berl); 1996 Sep; 127(2):140-9. PubMed ID: 8888380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidity of alcohol dependence with attention-deficit hyperactivity disorder: differences in phenotype with increased severity of the substance disorder, but not in genotype (serotonin transporter and 5-hydroxytryptamine-2c receptor).
    Johann M; Bobbe G; Putzhammer A; Wodarz N
    Alcohol Clin Exp Res; 2003 Oct; 27(10):1527-34. PubMed ID: 14574222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.